| |
| |
Gene Symbol |
ACTB |
| |
Aliases |
BRWS1, PS1TP5BP1 |
| |
Entrez Gene ID |
|
| |
Gene Name |
Actin beta |
| |
Chromosomal Location |
7p22.1 |
| |
HGNC ID |
|
| |
Summary |
This gene encodes one of six different actin proteins. Actins are highly conserved proteins that are involved in cell motility, structure, integrity, and intercellular signaling. The encoded protein is a major constituent of the contractile apparatus and one of the two nonmuscle cytoskeletal actins that are ubiquitously expressed. Mutations in this gene cause Baraitser-Winter syndrome 1, which is characterized by intellectual disability with a distinctive facial appearance in human patients. Numerous pseudogenes of this gene have been identified throughout the human genome. [provided by RefSeq, Aug 2017]
|
| |
RefSeq DNA |
|
| |
RefSeq mRNA |
|
| |
e!Ensembl
| Gene |
|
|
| Transcript |
ENST00000646664, ENST00000464611, ENST00000425660, ENST00000493945, ENST00000645576, ENST00000647275, ENST00000642480, ENST00000432588, ENST00000443528, ENST00000417101, ENST00000414620 |
|
| Protein |
ENSP00000494750, ENSP00000495059, ENSP00000409264, ENSP00000494269, ENSP00000496101, ENSP00000494185, ENSP00000495995, ENSP00000407473, ENSP00000393951, ENSP00000399487, ENSP00000401032
|
|
|
|
Gene Ontology (GO)
| GO ID |
Ontology |
Function |
Evidence |
Reference |
| GO:0001895 |
Biological process |
Retina homeostasis |
HEP |
23580065 |
| GO:0007409 |
Biological process |
Axonogenesis |
IBA |
21873635 |
| GO:0021762 |
Biological process |
Substantia nigra development |
HEP |
22926577 |
| GO:0022898 |
Biological process |
Regulation of transmembrane transporter activity |
IGI |
18331289 |
| GO:0022898 |
Biological process |
Regulation of transmembrane transporter activity |
ISS |
18331289 |
| GO:0043044 |
Biological process |
ATP-dependent chromatin remodeling |
HDA |
16217013 |
| GO:0048870 |
Biological process |
Cell motility |
IBA |
21873635 |
| GO:0048870 |
Biological process |
Cell motility |
IMP |
6202424 |
| GO:0051621 |
Biological process |
Regulation of norepinephrine uptake |
IGI |
18331289 |
| GO:0051621 |
Biological process |
Regulation of norepinephrine uptake |
ISS |
18331289 |
| GO:0051623 |
Biological process |
Positive regulation of norepinephrine uptake |
TAS |
18331289 |
| GO:0070527 |
Biological process |
Platelet aggregation |
HMP |
23382103 |
| GO:0072749 |
Biological process |
Cellular response to cytochalasin B |
IMP |
6202424 |
| GO:0098974 |
Biological process |
Postsynaptic actin cytoskeleton organization |
IDA |
18341992 |
| GO:1903076 |
Biological process |
Regulation of protein localization to plasma membrane |
IMP |
18331289 |
| GO:0000790 |
Cellular component |
Nuclear chromatin |
HDA |
16217013 |
| GO:0005615 |
Cellular component |
Extracellular space |
HDA |
16502470, 22664934, 23580065 |
| GO:0005634 |
Cellular component |
Nucleus |
IDA |
11687588 |
| GO:0005737 |
Cellular component |
Cytoplasm |
IBA |
21873635 |
| GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
24327345 |
| GO:0005737 |
Cellular component |
Cytoplasm |
TAS |
16130169 |
| GO:0005856 |
Cellular component |
Cytoskeleton |
IDA |
24327345 |
| GO:0005856 |
Cellular component |
Cytoskeleton |
TAS |
16130169 |
| GO:0005925 |
Cellular component |
Focal adhesion |
HDA |
21423176 |
| GO:0015629 |
Cellular component |
Actin cytoskeleton |
IBA |
21873635 |
| GO:0015629 |
Cellular component |
Actin cytoskeleton |
IDA |
11687588 |
| GO:0016020 |
Cellular component |
Membrane |
HDA |
19946888 |
| GO:0016020 |
Cellular component |
Membrane |
IBA |
21873635 |
| GO:0030424 |
Cellular component |
Axon |
IBA |
21873635 |
| GO:0031982 |
Cellular component |
Vesicle |
HDA |
19190083 |
| GO:0032991 |
Cellular component |
Protein-containing complex |
HDA |
16217013 |
| GO:0032991 |
Cellular component |
Protein-containing complex |
IDA |
11687588 |
| GO:0035267 |
Cellular component |
NuA4 histone acetyltransferase complex |
IBA |
21873635 |
| GO:0035267 |
Cellular component |
NuA4 histone acetyltransferase complex |
IDA |
10966108 |
| GO:0036464 |
Cellular component |
Cytoplasmic ribonucleoprotein granule |
IDA |
15121898 |
| GO:0045202 |
Cellular component |
Synapse |
IBA |
21873635 |
| GO:0070062 |
Cellular component |
Extracellular exosome |
HDA |
11487543, 19199708, 20458337, 21362503, 23533145 |
| GO:0072562 |
Cellular component |
Blood microparticle |
HDA |
22516433 |
| GO:0098793 |
Cellular component |
Presynapse |
TAS |
18331289 |
| GO:0098871 |
Cellular component |
Postsynaptic actin cytoskeleton |
EXP |
18341992 |
| GO:0098871 |
Cellular component |
Postsynaptic actin cytoskeleton |
IDA |
18341992 |
| GO:0098978 |
Cellular component |
Glutamatergic synapse |
EXP |
18341992 |
| GO:0098978 |
Cellular component |
Glutamatergic synapse |
IDA |
18341992 |
| GO:1990904 |
Cellular component |
Ribonucleoprotein complex |
IDA |
17289661 |
| GO:0000978 |
Molecular function |
RNA polymerase II proximal promoter sequence-specific DNA binding |
HDA |
16217013 |
| GO:0000980 |
Molecular function |
RNA polymerase II distal enhancer sequence-specific DNA binding |
HDA |
16217013 |
| GO:0005200 |
Molecular function |
Structural constituent of cytoskeleton |
TAS |
6202424 |
| GO:0005515 |
Molecular function |
Protein binding |
IPI |
11687588, 14592989, 15047060, 15161933, 15328537, 16189514, 16375898, 17192268, 17342765, 17404223, 17502619, 17599063, 17823310, 18331289, 18562541, 19000816, 19008859, 19328794, 19338310, 20473970, 20618440, 21044950, 21516116, 21555369, 21577206, 21969592, 23100250, 25416956, 259 |
| GO:0019894 |
Molecular function |
Kinesin binding |
IPI |
18680169 |
| GO:0019901 |
Molecular function |
Protein kinase binding |
IBA |
21873635 |
| GO:0019901 |
Molecular function |
Protein kinase binding |
IPI |
24327345 |
| GO:0030957 |
Molecular function |
Tat protein binding |
IPI |
16687403 |
| GO:0031492 |
Molecular function |
Nucleosomal DNA binding |
HDA |
16217013 |
| GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
16189514, 17404223, 18234857, 19000816, 20383143, 21516116, 25416956, 25910212 |
| GO:0048156 |
Molecular function |
Tau protein binding |
NAS |
28386764 |
| GO:0050998 |
Molecular function |
Nitric-oxide synthase binding |
IPI |
17502619 |
| GO:0098973 |
Molecular function |
Structural constituent of postsynaptic actin cytoskeleton |
EXP |
18341992 |
| GO:0098973 |
Molecular function |
Structural constituent of postsynaptic actin cytoskeleton |
IBA |
21873635 |
| GO:0098973 |
Molecular function |
Structural constituent of postsynaptic actin cytoskeleton |
IDA |
18341992 |
|
| Protein Information |
| |
Protein Name |
Actin, cytoplasmic 1, I(2)-actin, PS1TP5-binding protein 1, beta cytoskeletal actin |
| |
Function |
|
Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (PubMed:29581253). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (PubMed:29581253). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damaged DNA (PubMed:29925947). |
|
| |
|
|
| |
UniProt |
|
| |
PDB |
|
|
|
|
|
Interactions |
| | |
| STRING |
MINT |
IntAct |
| ENSP00000263826 |
Q9Y243 |
Q9Y243 |
|
| | |
View interactions
|
| |
| |
Associated Diseases
| Disease group | Disease Name | References |
| Cardiovascular Diseases |
| Myocardial Ischemia |
|
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| Baraitser-Winter syndrome |
23756437, 25052316, 10928857, 18414213, 23649928, 11311002, 10327243, 25741868, 22366783, 10411937, 26583190, 1415343 |
| Genetic Diseases |
|
| Anencephaly |
|
| Congenital ocular coloboma |
|
| Drachtman Weinblatt Sitarz syndrome |
|
| Ear Or Mastoid Diseases |
| Hearing Loss |
|
| Endocrine System Diseases |
| PCOS |
|
| Musculoskeletal Diseases |
| Arthritis |
|
| Osteoarthrosis Deformans |
|
| Dysostoses |
|
| Neoplasms |
| Esophagus Neoplasm |
|
| Lung Cancer |
|
| Liver Cancer |
|
| Anaplastic Carcinoma |
|
| Carcinoma |
|
| Nervous System Diseases |
| Dystonia |
|
| Psychiatric/Brain disorders |
| Bipolar Disorder |
|
| Intellectual Disability |
|
| Schizophrenia |
|
|
|
References |
| |
|
| |
| PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
ARHGAP4, ARHGAP9, RHOG, LYN, MYH9 |
PCOS, ovulatory dysfunction, hyperandrogenism, polycystic ovaries, insulin resistance, obesity, and dyslipidemia |
|
Rotterdam diagnostic criteria |
Related
|
7 PCOS granulosa samples and 3 control granulosa samples |
The Regulation of RhoA activity, Signaling by Rho GTPases, and GP VI-mediated activation cascade pathways may be associated with PCOS-related hormone imbalance and platelet dysfunction. LYN, ARHGAP4, ARHGAP9 and RHOG are promising candidate genes in PCOS, and may be recommended as possible therapeutic targets for PCOS. |
|
|
|